» Articles » PMID: 30441811

Epigenetic Regulation by LncRNAs: An Overview Focused on UCA1 in Colorectal Cancer

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2018 Nov 17
PMID 30441811
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancers have become the second leading cause of cancer-related deaths. In particular, acquired chemoresistance and metastatic lesions occurring in colorectal cancer are a major challenge for chemotherapy treatment. Accumulating evidence shows that long non-coding (lncRNAs) are involved in the initiation, progression, and metastasis of cancer. We here discuss the epigenetic mechanisms through which lncRNAs regulate gene expression in cancer cells. In the second part of this review, we focus on the role of lncRNA Urothelial Cancer Associated 1 (UCA1) to integrate research in different types of cancer in order to decipher its putative function and mechanism of regulation in colorectal cancer cells. UCA1 is highly expressed in cancer cells and mediates transcriptional regulation on an epigenetic level through the interaction with chromatin modifiers, by direct regulation via chromatin looping and/or by sponging the action of a diversity of miRNAs. Furthermore, we discuss the role of UCA1 in the regulation of cell cycle progression and its relation to chemoresistance in colorectal cancer cells.

Citing Articles

Epigenetic and epitranscriptomic role of lncRNA in carcinogenesis (Review).

Dai C, Qianjiang H, Fu R, Yang H, Shi A, Luo H Int J Oncol. 2025; 66(4).

PMID: 40017127 PMC: 11900940. DOI: 10.3892/ijo.2025.5735.


Long non-coding RNA Knockdown Assisted by CRISPR/Cas9 in Female Cancer Cell Lines Increases Mir-143 .

Montazeri-Najafabadi B, Doosti A, Kiani J Iran J Public Health. 2024; 53(4):934-946.

PMID: 39444484 PMC: 11493584. DOI: 10.18502/ijph.v53i4.15571.


Competitive endogenous RNA networks: Decoding the role of long non-coding RNAs and circular RNAs in colorectal cancer chemoresistance.

Khalafizadeh A, Hashemizadegan S, Shokri F, Bakhshinejad B, Jabbari K, Motavaf M J Cell Mol Med. 2024; 28(7):e18197.

PMID: 38506091 PMC: 10951891. DOI: 10.1111/jcmm.18197.


Long non-coding RNAs in cancer: multifaceted roles and potential targets for immunotherapy.

Kadian L, Verma D, Lohani N, Yadav R, Ranga S, Gulshan G Mol Cell Biochem. 2024; 479(12):3229-3254.

PMID: 38413478 DOI: 10.1007/s11010-024-04933-1.


Developmental origins of health and disease: Impact of paternal nutrition and lifestyle.

Shi Q, Qi K Pediatr Investig. 2023; 7(2):111-131.

PMID: 37324600 PMC: 10262906. DOI: 10.1002/ped4.12367.


References
1.
Ou C, Sun Z, Li X, Li X, Ren W, Qin Z . MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer. Cancer Lett. 2017; 399:53-63. DOI: 10.1016/j.canlet.2017.04.011. View

2.
Tian S, Zhao W, Yang D, Yu Y, Zou J, Liu Z . Atorvastatin inhibits miR-143 expression: A protective mechanism against oxidative stress in cardiomyocytes. Int J Cardiol. 2016; 211:115-8. DOI: 10.1016/j.ijcard.2016.02.141. View

3.
Lian Y, Yan C, Xu H, Yang J, Yu Y, Zhou J . A Novel lncRNA, LINC00460, Affects Cell Proliferation and Apoptosis by Regulating KLF2 and CUL4A Expression in Colorectal Cancer. Mol Ther Nucleic Acids. 2018; 12:684-697. PMC: 6083012. DOI: 10.1016/j.omtn.2018.06.012. View

4.
Xue M, Li X, Li Z, Chen W . Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1α-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion. Tumour Biol. 2014; 35(7):6901-12. DOI: 10.1007/s13277-014-1925-x. View

5.
Zeitels L, Acharya A, Shi G, Chivukula D, Chivukula R, Anandam J . Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis. Genes Dev. 2014; 28(23):2585-90. PMC: 4248289. DOI: 10.1101/gad.250951.114. View